Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

NCT03315052 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Delay in IRB approval

Conditions

Acute Cellular Graft Rejection
Liver Transplant Rejection

Interventions

DRUG: Budesonide
DRUG: Tacrolimus（FK506）
DRUG: Mycophenolate Mofetil
DRUG: Prednisone

Sponsor

Montefiore Medical Center